title: Reduced apoptosis rates in human schwannomas.
abstract: Schwannomas, tumors originating from Schwann cells, represent a frequent neurological tumor and can occur both in a genetic disorder called neurofibromatosis type 2 (NF2) and sporadically. In both cases the genetic background is identical as all schwannomas are caused by biallelic mutations in the tumor suppressor gene NF2 coding for merlin. Mutations in this gene have also been found to be responsible for 50% to 60% of spontaneous and 100% of the NF2 associated meningiomas. The NF2 gene product, merlin, links transmembrane proteins to the cytoskeleton and is involved in intracellular signaling processes. It has previously been shown that reexpression of wild-type merlin in primary human schwannoma cells leads to an increase in the number of apoptotic cells. Here, we report in vivo and in vitro evidence that the basal apoptosis rate of primary human schwannoma cells is reduced in comparison to that of normal Schwann cells, supporting the idea that in this benign tumor type, apoptosis has a role in tumorigenesis.
authors.affiliation: Department of Neurology, Zentrum für klinische Forschung, University of Ulm, Germany. Tamara.Utermark@medizin.uni-ulm.de
authors.forename: Tamara
authors.initials: T
authors.lastname: Utermark
authors.forename: Katherine
authors.initials: K
authors.lastname: Kaempchen
authors.forename: Gregor
authors.initials: G
authors.lastname: Antoniadis
authors.forename: C Oliver
authors.initials: CO
authors.lastname: Hanemann
mesh_terms: D000328:Adult; D017209:Apoptosis / Q000502:physiology*; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D006801:Humans; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D008875:Middle Aged; D009442:Neurilemmoma / Q000473:pathology*; D012583:Schwann Cells / Q000473:pathology*